Literature DB >> 19393722

Genetic contributions to avoidance-based decisions: striatal D2 receptor polymorphisms.

M J Frank1, K Hutchison.   

Abstract

Individuals differ in their tendencies to seek positive decision outcomes or to avoid negative ones. At the neurobiological level, our model suggests that phasic changes in dopamine support learning to reinforce good decisions via striatal D1 receptors, and to avoid maladaptive choices via striatal D2 receptors. Accordingly, in a previous study individual differences in positive and negative learning were strongly modulated by two genetic polymorphisms factors related to striatal D1 and D2 function, respectively. Nevertheless, whereas the role for dopamine in positive learning is relatively well accepted, that in learning to avoid negative outcomes is more controversial. Here we further explore D2-receptor-related genetic contributions to probabilistic avoidance in humans, in light of recent data showing that particular DRD2 polymorphisms are associated with functional modulation of receptor expression [Zhang Y, Bertolino A, Fazio L, Blasi G, Rampino A, Romano R, Lee M-LT, Xiao T, Papp A, Wang D, Sadée W (2007) Polymorphisms in human dopamine d2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci U S A 104(51):20552-20557]. We find that a promoter polymorphism rs12364283 associated with transcription and D2 receptor density was strongly and selectively predictive of avoidance-based decisions. Two further polymorphisms (rs2283265 and rs1076560) associated with relatively reduced presynaptic relative to postsynaptic D2 receptor expression were predictive of relative impairments in negative compared to positive decisions. These previously undocumented effects of DRD2 polymorphisms were largely independent of those we reported previously for the C957T polymorphism (rs6277) associated with striatal D2 density. In contrast, effects of the commonly studied Taq1A polymorphism on reinforcement-based decisions were due to indirect association with C957T. Taken together these findings suggest multiple D2-dependent genetic mechanisms contributing to avoidance. We discuss these effects in the context of neurocomputational models of reinforcement leaning in the basal ganglia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19393722      PMCID: PMC2760598          DOI: 10.1016/j.neuroscience.2009.04.048

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  63 in total

Review 1.  Opponent interactions between serotonin and dopamine.

Authors:  Nathaniel D Daw; Sham Kakade; Peter Dayan
Journal:  Neural Netw       Date:  2002 Jun-Jul

2.  Individual capacity differences predict working memory performance and prefrontal activity following dopamine receptor stimulation.

Authors:  Sasha E B Gibbs; Mark D'Esposito
Journal:  Cogn Affect Behav Neurosci       Date:  2005-06       Impact factor: 3.282

Review 3.  A neural substrate of prediction and reward.

Authors:  W Schultz; P Dayan; P R Montague
Journal:  Science       Date:  1997-03-14       Impact factor: 47.728

4.  Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism.

Authors:  U Finckh; H Rommelspacher; S Kuhn; P Dufeu; G Otto; A Heinz; M Dettling; M Giraldo-Velasquez; J Pelz; K J Gräf; H Harms; T Sander; L G Schmidt; A Rolfs
Journal:  Pharmacogenetics       Date:  1997-08

5.  Lack of allelic association of dopamine D1 and D2 (TaqIA) receptor gene polymorphisms with reduced dopaminergic sensitivity to alcoholism.

Authors:  A Heinz; T Sander; H Harms; U Finckh; S Kuhn; P Dufeu; M Dettling; K Gräf; A Rolfs; H Rommelspacher; L G Schmidt
Journal:  Alcohol Clin Exp Res       Date:  1996-09       Impact factor: 3.455

6.  A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol.

Authors:  Michael J Frank; Randall C O'Reilly
Journal:  Behav Neurosci       Date:  2006-06       Impact factor: 1.912

7.  C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo.

Authors:  M Hirvonen; A Laakso; K Någren; J O Rinne; T Pohjalainen; J Hietala
Journal:  Mol Psychiatry       Date:  2004-12       Impact factor: 15.992

8.  Gene-gene interaction associated with neural reward sensitivity.

Authors:  Juliana Yacubian; Tobias Sommer; Katrin Schroeder; Jan Gläscher; Raffael Kalisch; Boris Leuenberger; Dieter F Braus; Christian Büchel
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-02       Impact factor: 11.205

9.  Individual differences in reinforcement learning: behavioral, electrophysiological, and neuroimaging correlates.

Authors:  Diane L Santesso; Daniel G Dillon; Jeffrey L Birk; Avram J Holmes; Elena Goetz; Ryan Bogdan; Diego A Pizzagalli
Journal:  Neuroimage       Date:  2008-07-02       Impact factor: 6.556

10.  D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene.

Authors:  M Laruelle; J Gelernter; R B Innis
Journal:  Mol Psychiatry       Date:  1998-05       Impact factor: 15.992

View more
  66 in total

Review 1.  Neuropsychopharmacology and neurogenetic aspects of executive functioning: should reward gene polymorphisms constitute a diagnostic tool to identify individuals at risk for impaired judgment?

Authors:  Abdalla Bowirrat; Thomas J H Chen; Marlene Oscar-Berman; Margaret Madigan; Amanda Lh Chen; John A Bailey; Eric R Braverman; Mallory Kerner; John Giordano; Siobhan Morse; B William Downs; Roger L Waite; Frank Fornari; Zaher Armaly; Kenneth Blum
Journal:  Mol Neurobiol       Date:  2012-02-28       Impact factor: 5.590

Review 2.  Opponency revisited: competition and cooperation between dopamine and serotonin.

Authors:  Y-Lan Boureau; Peter Dayan
Journal:  Neuropsychopharmacology       Date:  2010-09-29       Impact factor: 7.853

3.  An Obesity-Predisposing Variant of the FTO Gene Regulates D2R-Dependent Reward Learning.

Authors:  Meltem Sevgi; Lionel Rigoux; Anne B Kühn; Jan Mauer; Leonhard Schilbach; Martin E Hess; Theo O J Gruendler; Markus Ullsperger; Klaas Enno Stephan; Jens C Brüning; Marc Tittgemeyer
Journal:  J Neurosci       Date:  2015-09-09       Impact factor: 6.167

4.  Explicit and implicit reinforcement learning across the psychosis spectrum.

Authors:  Deanna M Barch; Cameron S Carter; James M Gold; Sheri L Johnson; Ann M Kring; Angus W MacDonald; Diego A Pizzagalli; J Daniel Ragland; Steven M Silverstein; Milton E Strauss
Journal:  J Abnorm Psychol       Date:  2017-04-13

5.  Altered probabilistic learning and response biases in schizophrenia: behavioral evidence and neurocomputational modeling.

Authors:  James A Waltz; Michael J Frank; Thomas V Wiecki; James M Gold
Journal:  Neuropsychology       Date:  2011-01       Impact factor: 3.295

6.  From the genome to the phenome and back: linking genes with human brain function and structure using genetically informed neuroimaging.

Authors:  H R Siebner; J H Callicott; T Sommer; V S Mattay
Journal:  Neuroscience       Date:  2009-09-12       Impact factor: 3.590

Review 7.  Neurobehavioral evidence for changes in dopamine system activity during adolescence.

Authors:  Dustin Wahlstrom; Tonya White; Monica Luciana
Journal:  Neurosci Biobehav Rev       Date:  2009-12-21       Impact factor: 8.989

8.  The C957T polymorphism in the dopamine receptor D₂ gene modulates domain-general category learning.

Authors:  Zilong Xie; W Todd Maddox; John E McGeary; Bharath Chandrasekaran
Journal:  J Neurophysiol       Date:  2015-03-11       Impact factor: 2.714

9.  Beyond the bilingual advantage: The potential role of genes and environment on the development of cognitive control.

Authors:  Arturo E Hernandez; Maya R Greene; Kelly A Vaughn; David J Francis; Elena L Grigorenko
Journal:  J Neurolinguistics       Date:  2015-05-16       Impact factor: 1.710

10.  Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants.

Authors:  Ajna Hamidovic; Andrea Dlugos; Andrew Skol; Abraham A Palmer; Harriet de Wit
Journal:  Exp Clin Psychopharmacol       Date:  2009-12       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.